Ceyda Acilan

12PUBLICATIONS
38CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Main group metal chemistryCancer cell biologyTransition metal chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 17, 2026
Nicotinamide N-methyltransferase as a therapeutic target in taxane-resistant castration-resistant prostate cancer.

|Jan 07, 2026
Identification of epigenetic monotherapy candidates in taxane-resistant CRPC.

Buse Cevatemre, İpek Bulut, Ezgi Karyemez

|Jul 18, 2025
Butyrylcholinesterase (BChE) downregulation in taxane resistance: implications for prostate cancer.

Buse Cevatemre, Arda Işiklar, İpek Bulut

|Jun 29, 2025
Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer.

Ozlem Yedier-Bayram, Ahmet Cingöz, Ebru Yilmaz

|May 17, 2024
Enhanced selectivity towards melanoma cells with zinc(II)-Schiff bases containing imidazole derivatives.

Leonor Côrte-Real, Baris Sergi, Busra Yildirim

|Mar 17, 2024
Nek2A prevents centrosome clustering and induces cell death in cancer cells via KIF2C interaction.

Batuhan Mert Kalkan, Selahattin Can Ozcan, Enes Cicek

Pageof 2

Frequent Collaborators

5 joint publications

Buse Cevatemre

3 joint publications

Ipek Bulut

2 joint publications

Hamzah Syed

2 joint publications

Tugba Bagci-Onder